• OPEN AN ACCOUNT
Indian Indices
Nifty
26,202.95 -12.60
(-0.05%)
Sensex
85,706.67 -13.71
( -0.02%)
Bank Nifty
59,752.70 15.40
( 0.03%)
Nifty IT
37,405.50 -40.80
( -0.11%)
Global Indices
Nasdaq
47,737.43 289.30
(0.61%)
Dow Jones
6,869.48 35.87
(0.52%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,721.02 27.09
(0.28%)
Forex
USD-INR
89.30 0.10
(0.11%)
EUR-INR
103.54 0.22
(0.21%)
GBP-INR
118.23 0.49
(0.41%)
JPY-INR
0.57 0.00
(0.17%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.5672424
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
19.45
105007.87
EPS(TTM)
Face Value()
Div & Yield %
64.68
1
0.64
 

Tahmar Enterprises reports standalone net loss of Rs 0.50 crore in the September 2025 quarter
Nov 15,2025
Net Loss of Tahmar Enterprises reported to Rs 0.50 crore in the quarter ended September 2025 as against net loss of Rs 0.50 crore during the previous quarter ended September 2024. Sales declined 68.97% to Rs 0.18 crore in the quarter ended September 2025 as against Rs 0.58 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.180.58 -69
OPM %-805.56-268.97 -
PBDT-0.49-0.48 -2
PBT-0.50-0.50 0
NP-0.50-0.50 0